| 000 | 01604 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518004051.0 | ||
| 264 | 0 | _c20191223 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a2173-5778 | ||
| 024 | 7 |
_a10.1016/j.ad.2018.09.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCubiró, X | |
| 245 | 0 | 0 |
_aThe Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months' Evolution and Prior Immunosuppressive Treatment. _h[electronic resource] |
| 260 |
_bActas dermo-sifiliograficas _cMay 2019 |
||
| 300 |
_a289-296 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOmalizumab _xtherapeutic use |
| 650 | 0 | 4 | _aPragmatic Clinical Trials as Topic |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrticaria _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSpertino, J | |
| 700 | 1 | _aRozas-Muñoz, E | |
| 700 | 1 | _aSerra-Baldrich, E | |
| 700 | 1 | _aPuig, L | |
| 773 | 0 |
_tActas dermo-sifiliograficas _gvol. 110 _gno. 4 _gp. 289-296 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ad.2018.09.009 _zAvailable from publisher's website |
| 999 |
_c28978163 _d28978163 |
||